Into clinical practice:

Meeting the challenges of Gram-negative infection management

- held 14 October 2021. View the recorded content below

View the recorded content from this hybrid conference which explores the current challenges and treatment opportunities for Gram-negative infections. Delegates will, through plenary lectures, learn about resistance mechanisms, clinical presentations of Gram-negatives and the latest in research and development.

This conference is RCPath CPD accredited.

View the conference brochure here Access brochure

Programme

SESSION ONE: OVERVIEW OF THE GRAM NEGATIVE INFECTIONS LANDSCAPE
This session is of the following presentations:
What’s left in the cupboard? Older antimicrobials for treating gonorrhoea
Dr Helen Fifer, Consultant microbiologist, UK Health Security Agency (UKHSA)
Recent updates from EUCAST: the impact of guidance on MDT practices
Dr Nick Brown, Consultant Medical Microbiologist, Cambridge University Hospitals NHS Trust
Exotic and imported infections: Burkholderia pseudomallei
Professor David Dance, Honorary Visiting Research Fellow/Honorary Professor, Lao-Oxford-Mahosot Hospital- Wellcome Trust Research Unit/University of Oxford/ London School of Hygiene and Tropical Medicine
NICE funding models - what do we want next for delinkage?
Miss Beth Woods, Senior Research Fellow, University of York
Q&A

SESSION THREE: A ONE HEALTH VIEW ON ANTIMICROBIAL RESISTANCE
This session is of the following presentations:
Veterinary approaches to antimicrobial use and stewardship
Professor Roberto La Ragione, Head of the Department of Pathology and Infectious Diseases and Deputy Head of the School of Veterinary Medicine, University of Surrey
Antimicrobials in the environment – how much is too much?
Dr Aimee Murray, Lecturer, University of Exeter
Protecting the environment through legislation
Natalie Louise Bennett, Baroness Bennett of Manor Castle
Q&A

SESSION FIVE: WHAT LESSON HAVE WE LEARNT ON AMR?
This session is of the following presentations:
What has been the impact of COVID-19 on Gram-negative resistance?
Dr Sarah Gerver, Head of the Antimicrobial Resistance and Prescribing Section at the UK Health Security Agency
Optimising antimicrobial prescribing
Mrs Frances Garraghan, Lead Antimicrobial Pharmacist, Manchester University NHS Foundation Trust
Debate - stewardship in the era of COVID-19
Mrs Frances Garraghan, Lead Antimicrobial Pharmacist, Manchester University NHS Foundation Trust & Dr Alicia Demirjian, Consultant, Paediatric Infectious Diseases; Epidemiologist Evelina London Children’s Hospital; UK Health Security Agency (UKHSA)

Having trouble finding what you're after?

Top